DOC
Healthpeak PropertiesNYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-05-08
As of May 8, 2026, DOC has a mixed analyst signal with a composite score of 2.3 and a medium confidence level of 70.9. The score is influenced by various factors, including a favorable outlook if next-quarter guidance is raised, but it could decline if the real estate sector trend weakens. The top drivers affecting the score include macroeconomic factors such as rates, growth, labor, and inflation. This analysis is provisional.
Price
Daily closes from AlphaVantage. Earnings/event dots are placed inline.
Factor signals
Read top-to-bottom: thesis (is this a strong company over a 1–3 year hold), watch flags (has something changed worth re-reading), and position context (how violent might the path be). Each pill is a parallel diagnostic — never aggregated into a single score.
Thesis
— is this a strong company over a 1–3 year hold?Why this rank
- Direction share1.00
- Slope (norm)0.58
- Bonus0.00
Why this rank
Trailing four: 2024-Q3, 2025-Q1, 2025-Q2, 2025-Q3
Why this rank
Joint read: strong + robust historically delivered 80%+ NI-grew rate over T+1y in IT 2024–26 (small N).
Watch
— has something changed worth re-reading?Why this setup
EPS estimate $0.05 → $0.05 (-3.3% / 30d). 0 raised, 0 cut, 6 covering analysts.
0 upgrades, 0 downgrades / 30d, 1 maintained. 50% of analysts rate Buy.
2 PT revisions / 30d. Avg target 5.8% above current price.
1 positive, 0 negative / 30d. See F4 management tile for the event list.
F4 · Management deep-dive — recent events, stated priorities, guidance track record
Recent 8-K events
No recent events recorded.
Stated priorities
3 priorityies extracted from earnings transcripts (as of 2026-05-08).
- 1.Reaffirming 2026 NOI growth guidancegrowthmixed39% progress
5/5: “We are reaffirming full year 2026 Total Same-Store Cash (Adjusted) NOI growth in the range of (1.0%) – 1.0%.”
Why this status
Stated in 2 of last 2 quarters. Healthpeak reaffirmed its 2026 NOI growth guidance range of (1.0%) to 1.0%. Despite the reaffirmation, financials show a net income of $321.9M in 2025-Q4, up from a loss of $117.1M in 2025-Q3, indicating some positive trajectory but limited progress towards the upper end of the guidance range.
- 2.Updating 2026 EPS guidancegrowthmixed39% progress
5/5: “We are updating the following guidance ranges for full year 2026: • Diluted earnings per common share from $0.34 – $0.38 to $0.46 – $0.50.”
Why this status
Stated in 2 of last 2 quarters. Healthpeak updated its 2026 EPS guidance to $0.46 – $0.50. The financials show a net income increase from $6.7M in 2025-Q1 to $321.9M in 2025-Q4, suggesting a positive trajectory towards achieving the updated EPS guidance.
- 3.Reaffirming 2026 FFO guidancegrowthmixed39% progress
5/5: “Diluted Nareit FFO per share from $1.70 – $1.74 to $1.68 – $1.72.”
Why this status
Stated in 2 of last 2 quarters. Healthpeak reaffirmed its 2026 FFO guidance range of $1.68 to $1.72. Despite the reaffirmation, revenue decreased from $705.9M in 2025-Q3 to $693.7M in 2025-Q4, indicating limited progress towards achieving the FFO guidance.
Guidance track record
Insufficient guidance history for this ticker.
Position context
— how violent might the path be while I hold it?Why this risk level
Recent vol — 30d annualized 53%; 252d 29%.
Drawdown — Max 1y −17%. Bad day move −2%.
Beta to sector ETF (XLRE) — 1.16 over 1y.
Liquidity — score 100/100.
Sub-scores — vol 52/100, drawdown 66/100, beta 84/100, earnings vol —.
via XLRE
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive — historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only — describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-05-08.
What changed
The most important moves since the prior daily snapshot.
- No material changes since the prior snapshot.
No material changes since the prior snapshot.
as of 2026-05-08
Management scorecard
How management runs the business — capital, margins, balance sheet, and how reliably they guide and deliver.
What management is focused on
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
- #1
Reaffirming 2026 NOI growth guidance
GrowthNew since 2026-05-05Healthpeak is reaffirming its full year 2026 Total Same-Store Cash (Adjusted) NOI growth guidance in the range of (1.0%) to 1.0%.
MixedStated in 2 of last 2 quarters. Healthpeak reaffirmed its 2026 NOI growth guidance range of (1.0%) to 1.0%. Despite the reaffirmation, financials show a net income of $321.9M in 2025-Q4, up from a loss of $117.1M in 2025-Q3, indicating some positive trajectory but limited progress towards the upper end of the guidance range.
39%CEO/CFO:“We are reaffirming full year 2026 Total Same-Store Cash (Adjusted) NOI growth in the range of (1.0%) – 1.0%.”Multiple sourcesSource dated 2026-05-05Stated 2 of last 8 quartersFirst seen 2026-05-05Show history (2)
- 2026-Q1Multiple sources
“Total Merger-Combined Same-Store Cash (Adjusted) NOI growth of (1%) – 1%”
- 2025-Q4Multiple sources
“Total Merger-Combined Same-Store Cash (Adjusted) NOI growth of (1%) – 1%”
- #2
Updating 2026 EPS guidance
GrowthNew since 2026-05-05Healthpeak updated its full year 2026 EPS guidance from $0.34 – $0.38 to $0.46 – $0.50.
MixedStated in 2 of last 2 quarters. Healthpeak updated its 2026 EPS guidance to $0.46 – $0.50. The financials show a net income increase from $6.7M in 2025-Q1 to $321.9M in 2025-Q4, suggesting a positive trajectory towards achieving the updated EPS guidance.
39%CEO/CFO:“We are updating the following guidance ranges for full year 2026: • Diluted earnings per common share from $0.34 – $0.38 to $0.46 – $0.50.”Multiple sourcesSource dated 2026-05-05Stated 2 of last 8 quartersFirst seen 2026-05-05Show history (2)
- 2026-Q1Multiple sources
“Diluted earnings per common share from $0.34 – $0.38 to $0.46 – $0.50”
- 2025-Q4Multiple sources
“Diluted earnings per common share from $0.34 – $0.38”
- #3
Reaffirming 2026 FFO guidance
GrowthNew since 2026-05-05Healthpeak reaffirmed its full year 2026 FFO per share guidance in the range of $1.68 to $1.72.
MixedStated in 2 of last 2 quarters. Healthpeak reaffirmed its 2026 FFO guidance range of $1.68 to $1.72. Despite the reaffirmation, revenue decreased from $705.9M in 2025-Q3 to $693.7M in 2025-Q4, indicating limited progress towards achieving the FFO guidance.
39%CEO/CFO:“Diluted Nareit FFO per share from $1.70 – $1.74 to $1.68 – $1.72.”Multiple sourcesSource dated 2026-05-05Stated 2 of last 8 quartersFirst seen 2026-05-05Show history (2)
- 2026-Q1Multiple sources
“Diluted Nareit FFO per share from $1.70 – $1.74 to $1.68 – $1.72”
- 2025-Q4Multiple sources
“Diluted Nareit FFO per share of $1.70 – $1.74”
How this stock is priced
Two ways to read price: against peers in the same business, and against the company's own history.
Looks cheaper than most peers in the same business.
Richer than its own typical valuation.
P/E over the last 5 years
64 monthly pointsHow this compares
A side-by-side read on composite, valuation, and risk versus peers.
| Stock | Composite | Valuation | Risk |
|---|---|---|---|
DOC Healthpeak Properties | +2.3 | fair | moderate |
WELL Welltower | +7.9 | expensive | low |
PLD Prologis | +10 | full | low |
EQIX Equinix | +22 | fair | moderate |
AMT American Tower | +18 | fair | moderate |
Risk — how this stock moves
What a normal day looks like, what a bad day looks like, and the worst the last year has thrown at it.
What could change this view
Conditional scenarios — if X happens, the score would shift by about Y points. These are not predictions.
- If next-quarter guidance is raised (currently LOWERED as of 2026-05-05)+16 pts
- If real_estate sector trend rises from +0.00 into 'improving' (>= +0.20)+5.0 pts
- If next-quarter EPS surprise repeats current direction (latest surprise +234.9% on 2026-03-31)+2.4 pts
- If rates state reverses from -0.37 (negative) to +0.37 (positive)-8.0 pts
- If real_estate sector trend falls from +0.00 into 'weakening' (<= -0.20)-5.0 pts
Material updates
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
- 2026-05-054d agoItem 2.02
Results of Operations and Financial Condition. On May 5, 2026, Healthpeak Properties, Inc., a Maryland corporation (“Healthpeak”), issued a press release setting forth its financial results for the first quarter and three months ended March 31, 2026. The press release refers to the Discussion and Reconciliation of Non-GAAP Financial Measures, which is available in the Investor Relations section of Healthpeak’s website, free of charge, at http://ir.healthpeak.com/quarterly-results . The press…
earnings preannouncementpositivescore 66
Score history
The composite score, snapshot by snapshot. The dotted line at zero separates leaning-positive from leaning-negative.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.